Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for HUTCHMED (China) (HCM) over the last 11 years, with Q2 2025 value amounting to $342.3 million.

  • HUTCHMED (China)'s Total Current Liabilities fell 828.82% to $342.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $342.3 million, marking a year-over-year decrease of 828.82%. This contributed to the annual value of $353.9 million for FY2022, which is 1355.49% up from last year.
  • Per HUTCHMED (China)'s latest filing, its Total Current Liabilities stood at $342.3 million for Q2 2025, which was down 828.82% from $373.3 million recorded in Q2 2024.
  • In the past 5 years, HUTCHMED (China)'s Total Current Liabilities registered a high of $373.3 million during Q2 2024, and its lowest value of $188.5 million during Q1 2021.
  • Its 5-year average for Total Current Liabilities is $310.0 million, with a median of $331.4 million in 2022.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first soared by 10748.91% in 2021, then crashed by 828.82% in 2025.
  • Quarter analysis of 5 years shows HUTCHMED (China)'s Total Current Liabilities stood at $311.7 million in 2021, then rose by 13.55% to $353.9 million in 2022, then fell by 3.68% to $340.9 million in 2023, then increased by 9.51% to $373.3 million in 2024, then decreased by 8.29% to $342.3 million in 2025.
  • Its last three reported values are $342.3 million in Q2 2025, $373.3 million for Q2 2024, and $340.9 million during Q2 2023.